INFECTION AND IMMUNITY: STRATEGIES FROM BOTH SIDES
https://doi.org/10.15789/1563-0625-2006-5-6-597-614
Abstract
Abstract. The review considers contemporary data concerning the mechanisms of interaction between infectious agents and host immune system. The ways for evasion of the host immune reactions are described, and “behavioral” patterns are provided for particular pathogens, e.g., viruses, bacteria, protozoa, helminthes. The diversity of cells and soluble mediators participating in the immune response is discussed.
About the Author
G. F. Zheleznikova
ФГУ НИИ детских инфекций Росздрава, Санкт-Петербург
Russian Federation
Russian Federation
References
1. Атауллаханов Р.И., Гинцбург А.Л. Иммунитет и инфекция: динамичное противостояние живых систем // Детские инфекции. - 2005. - Т.4. - №1. - С.11-21.
2. Глазанова Т.В., Бубнова Л.Н., Мазуров В.И. Аутоиммунные заболевания щитовидной железы: роль иммунологических и иммуногенетических факторов // Мед. Иммунол. - 2000. - Т.2. - №3. - С.257-270.
3. Железникова Г.Ф. Иммуноглобулин Е: биологическая роль при инфекционных заболеваниях // Мед. Иммунол. - 2002. - Т. 4. - № 4-5. - С.515-534.
4. Кетлинский С.А. Роль гетеродимерных цитокинов семейства ИЛ-12 в развитии и регуляции врожденного иммунитета и TH1 иммунного ответа // Мед. акад. журн. - 2005. - Т.5. - № 3. - С.13-27.
5. Рассеянный склероз. Клинические аспекты и спорные вопросы / Под ред. А.Дж. Томпсона, К. Полмана, Р.Холфельда: Перевод с англ. - СПб.: Политехника, 2001. - 422 с.
6. Сенников С.В., Силков А.Н., Козлов В.А. Роль альтернативного сплайсинга генов цитокинов в формировании полиморфной структуры цитокиновой сети // Мед. Иммунол. - 2001. - Т. 3. - № 3. - С.389-400.
7. Симбирцев А.С. Цитокины: классификация и биологические функции // Цитокины и воспал. - 2004. - Т. 3. - № 2. - С.16-22.
8. Симбирцев А.С. Цитокинзависимые наследственные иммунодефицитные состояния // Рос. Аллергол. Журн. - 2005. - № 3. - С.27-40.
9. Смольникова М.В., Коненков В.И. Клиническая иммуногенетика заболеваний человека // Мед. Иммунол. - 2001. - Т. 3. - № 3. - С.379-389.
10. Сорокина М.Н., Скрипченко Н.В. Вирусные энцефалиты и менингиты у детей: Руководство для врачей. - М.: ОАО «Издательство «Медицина», 2004. - 416 с.
11. Старшинов Я.Ю. Клинико-лучевые и иммунологические особенности диссеминированных энцефаломиелитов у детей. Автореф. дис…к.м.н. СПб., 2003. - 23 с.
12. Тотолян А.А. Роль хемокинов и их рецепторов в иммунорегуляции // Иммунол. - 2001. - № 5. - С.7-15.
13. Ярилин А.А., Донецкова А.Д. Регуляторные Foxp3+ Т-клетки и их роль при аллергии // Рос. Аллергол. Журн. - 2005. - № 2. - С.22-26.
14. Ahmad A., Ahmad R. HIV’s evasion of host’s NK cell response and novel ways of its countering and boosting anti-HIV immunity // Current HIV Res. - 2003. - Vol.1. - N3. - P. 295-307.
15. Arend W. The balance between IL-1 and IL-1Ra in disease // Cytokine Growth Factor Rev. - 2002. - Vol.13. - P.323-340.
16. Baillie J., Sahlender D., Sinclair J. Human cytomegalovirus infection inhibits tumor necrosis factor alpha (TNF-α) signaling by targeting the 55-kilodalton TNF-α receptor // J. Virol. - 2003. - Vol.77. – N 12. - P.7007-7016.
17. Barnes K. Parasite evolution and the immune system // Allergy Clin. Immunol. Int. - J. World Allergy Org. 2005. - Vol.17. - P.229-236.
18. Benedict C., Ware C. Virus targeting of the tumor necrosis factor superfamily // Virology. - 2001. - Vol.289. - N 1. - P.1-5.
19. Benson M., Strannegard I., Wennergren G., Strannegard O. Increase of the soluble IL-4 receptor (IL-4sR) and positive correlation between IL-4sR and IgE in nasal fluids from school children with allergic rhinitis // Allergy Asthma Proc. - 2000. - Vol.21. - N 2. - P.89-95.
20. Bogdan C., Mattner J., Schleicher U. The role of type I interferons in non-viral infections // Immunol. Rev. - 2004. - Vol. 202. - P.33-48.
21. Bradley C., Griffiths N., Rowe H., Heyderman R., Virji M. Critical determinants of the interaction of capsule-expressing Neisseria meningitidis with host cells: the role of receptor density in increased cellular targeting via the outer membrane Opa proteins // Cell. Microbiol. - 2005. - Vol.7. - N 10. - P.1490-1503.
22. Brand S., Beigel F., Olstak T., Zitzmann K., Eichhorst S., Otte J., Diebold J., Diepolder H., Adler B., Auernhammer C., Goke B., Dambacher J. IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression // Am. J. Physiol. Gastrointest. Liver Physiol. - 2005. - Vol.289. - N 5. - P.960-968.
23. Brodsky M. Stealth, sabotage and exploitation // Immunol. Rev. - 1999. - Vol.168. - P.5-11.
24. Brombacher F., Kastelein R., Alber G. Novel IL-12 family members shed light on the orchestration of Th1 responses // Trends Immunol. - 2003. - Vol.24. - N 4. - P.207-212.
25. Calandra T. Macrophage migration inhibitory factor and host innate immune responses to microbes // Scand. J. Infect. Dis. - 2003. - Vol.35. - N 9. - P.573-576.
26. Cameron S., Nawijn M., Kum W., Savelkoul H., Chow A. Regulation of T cell responses to staphylococcal superantigens // Eur. Cytokine Netw. - 2001. - Vol.12. - N 2. - P.210-222.
27. Carosella E., Moreau P., Aractingi S., Rouas-Freiss N. HLA-G: a shield against inflammatory aggression // Trends Immunol. - 2001. - Vol.22. - N 10. - P.553-555.
28. Chan K., Phillips A., Walker-Smith J. A., MacDonald T.T. Serum IL-2 receptor in infants and young children // Acta Paediatr. - 1995. - Vol.84. - N 2. - P.151-156.
29. Cheng J., Imanishi H., Morisaki H., Liu W., Nakamura H., Morisaki T., Hada T. Recombinant HBsAg inhibits LPS-induced COX-2 expression and IL-18 production by interfering with the NFkappaB pathway in a human monocytic cell line, THP-1 // J. Hepatol. - 2005. - Vol.43. - N 3. - P.465-471.
30. Chensue S. Molecular machinations: chemokine signals in host-pathogen interactions // Clin. Microbiol. Rev. - 2001. - Vol.14. - N 4. - P.821-835.
31. Chevillard C., Moukoko C., Elwali N., Bream J., Kouriba B., Argiro L., Rahood S., Mergani A., Henri S., Gaudart J., Mohamed-Ali Q., Young H., Dessein A. IFN-gamma polymorphisms (IFN-gamma +2109 and IFN-gamma +3810) are associated with severe hepatic fibrosis in human hepatic schistosomiasis (Schistosoma mansoni) // J. Immunol. - 2003. - Vol.171. - P.5596-5601.
32. Dheda K., Chang J., Breen R., Haddock J., Lipman M., Kim L., Huggett J., Johnson M., Rook G., Zumla A. Expression of a novel cytokine, IL-4delta2, in HIV and HIV-tuberculosis co-infection // AIDS. - 2005. - Vol.19. - N 15. - P.1601-1606.
33. Diao J., Khine A., Sarangi F., Hsu E., Iorio C., Tibbles L., Woodgett J., Penninger J., Richardson C. X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated with upregulation of the SARK/JNK pathway // J. Biol. Chem. - 2000. Nov. 30.
34. Erdman S., Rao V., Poutahidis T., Ihrig M., Ge Z., Feng Y., Tomczak M., Rogers A., Horwitz B., Fox J. CD4+CD25+ regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice // Cancer Res. - 2003. - Vol.63. - N 18. - P.6042-6050.
35. Fickensher H., Hor S., Kupers H., Knappe A., Wittman S., Sticht H. The interleukin-10 family of cytokines // Trends Immunol. - 2002. - Vol.23. - N 2. - P.89-96.
36. Fort M., Cheung J., Yen D., Li J., Zurawski S.M., Lo S., Menon S., Clifford T., Hunte B., Lesley R., Muchamuel T., Hurst S.D., Zurawski G., Leach M.W., Gorman D.M., Rennick D.M. IL-25 induces IL-4, IL-5 and IL-13 and Th2-associated pathologic in vivo // Immunity. - 2001. - Vol.15. - P.985-995.
37. Gealy C., Denson M., Humphreys C., McSharry B., Wilkinson G., Caswell R. Posttranscriptional suppression of IL-6 production by human cytomegalovirus // J. Virol. - 2005. - Vol.79. - N 1. - P.472-485.
38. Gotoh B., Komatsu T., Takeuchi K., Yokoo J. Paramixoviruses accessory proteins as interferon antagonists // Microbiol. Immunol. - 2001. - Vol.45. - N 12. - P.787-800.
39. Gotoh B., Komatsu T., Takeuchi K., Yokoo J. Paramixoviruses strategies for evading the interferon response // Rev. Med. Virol. - 2002. - Vol.12. - N 6. - P.337-357.
40. Guerrero-Plata A., Ortega E., Gomez B. Persistence of respiratory syncytial virus in macrophages alters phagocytosis and pro-inflammatory cytokine production // Viral. Immunol. - 2001. - Vol.14. - N 1. - P.19-30.
41. Guglietta S., Garbuglia A., Pacciani V., Scotta C., Perrone M., Laurenti L., Spada E., Mele A., Capobianchi M., Taliani G., Folgori A., Vitelli A., Ruggeri L., Nicosia A., Piccolella E., Del Porto P. Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection // Eur. J. Immunol. - 2005. - Vol.35. - N 9. - P.2627-2637.
42. Hahm B., Trifilo M., Zuniga E., Oldstone M. Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling // Immunity. - 2005. - Vol.22. - N 2. - P.247-257.
43. Hamerman Y., Ogasawa K., Lanier L. NK cells in innate immunity // Curr. Opin. Immunol. - 2005. - Vol.17. - N 1. - P.29-35.
44. Haring J., Pewe L., Perlman S. Bystander CD8 T cell-mediated demyelination after viral infection of the central nervous system // J. Immunol. - 2002. - Vol.169. - N 3. - P. 1550-1555.
45. He Y., Katze M. To interfere and to anti-interfere: the interplay between hepatitis C virus and interferon // Viral Immunol. - 2002. - Vol.15. - N 1. - P.95-119.
46. Henri S., Chevillard C., Mergani A., Paris P., Gaudart J., Camilla C., Dessein H., Montero F., Elwali N., Saeed O., Magzoub M., Dessein A. Cytokine regulation of periportal fibrosis in humans infected with Schistosoma mansoni: IFN-gamma is associated with protection against fibrosis and TNF-alpha with aggravation of disease // J. Immunol. - 2002. - Vol.169. - P.929-936.
47. Heuer J., Zhang T., Zhao J., Ding C., Cramer M., Justen K., Vonderfecht S., Na S. Adoptive transfer of in vitro-stimulated CD4+CD25+ regulatory T cells increases bacterial clearance and improves survival in polymicrobial sepsis // J. Immunol. - 2005. - Vol.174. - N 11. - P.7141-7146.
48. Holsher C. The power of combinatorial immunology: IL-12 and IL-12-related dimeric cytokines in infectious diseases // Med. Mictobiol. Immunol. - 2004. - Vol.193. - N 1. - P.1-17.
49. Hurst S., Muchamuel T., Gorman D., Gilbert J.M., Clifford T., Kwan S., Menon S., Seymour B., Jackson C., Kung T.T., Brieland J.K., Zurawski S.M., Chapman R.W., Zurawski G., Coffman R.L. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25 // J. Immunol. - 2002. - Vol.169. - N 1. - P 443-453.
50. Janeway C. How the immune system works to protect the host from infection: a personal view // Proc. Natl. Acad. Sci. USA. - 2001. - Vol.98. - P.7461-7468.
51. Jenkins C., Abendroth A., Slobedman B. A novel viral transcript with homology to human IL-10 is expressed during latent human cytomegalovirus infection // J. Virol. - 2004. - Vol.78. - N 3. - P.1440-1447.
52. Katano H., Ali M., Patera A., Catalfamo M., Jaffe E., Kimura H., Dale J., Straus S., Cohen J. Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation // Blood. - 2004. - Vol.15. - N 4. - P.1244-1252.
53. Khakoo S., Thio C., Martin M., Brooks C.R., Gao X., Astemborski J., Cheng J., Goedert J.J., Vlahov D., Hilgartner M., Cox S., Little A.M., Alexander G.J., Gramp M.E., O’Brien S.J., Rosenberg W.M., Thomas D.L., Carrington M. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection // Science. - 2004. - Vol.305. - P.872-874.
54. Kim S.-H., Han S.-Y., Azam T., Yoon D.-Y., Dinarello Ch. Interleukin-32: a cytokine and inducer of TNFa // Immunity. - 2005. - Vol.22. - N 1. - P.131-142.
55. Li L., Greenwald R., Lafuente E., Tzachanis D., Berezovskaya A., Freeman G., Sharpe A., Boussiotis V. Rap1-GTP is a negative regulator of Th cell function and promotes the generation of CD4+CD103+ regulatory T cells in vivo // J. Immunol. - 2005. - Vol.175. - N 1. - P.3133-3139.
56. Loenen W., Bruggeman C., Wiertz E. Immune evasion by human cytomegalovirus: lessons in immunology and cell biology // Semin. Immunol. - 2001. - Vol.13. - N 1. - P.41-49.
57. Lu C., Sheu B., Chen T., Yang H., Hung K., Kao A., Chuang C., Wu J. Host TNF-alpha-1031 and -863 promoter single nucleotide polymorphisms determine the risk of benign ulceration after H. pylory infection // Am. J. Gastroenterol. - 2005. - Vol.100. - N 6. - P. 1274-1284.
58. McDonald A., Duffy M., Brady T.M., McKiernan S., Hall W., Hegarty J., Curry M., Mills K. CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in HCV-infected persons // J. Infect. Dis. - 2002. - Vol.185. - P.720-727.
59. McGuirk P., McCann C., Mills K. Pathogenspecific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates IL-10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis // J. Exp. Med. - 2002. - Vol.195. - N 2. - P.221-231.
60. McGuirk P., Mills K. Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases // Trends Immunol. - 2002. - Vol.23. - N 9. - P.450-455.
61. Meyer C., May J., Luty A., Lell B., Kremsner P. TNFalpha-308A associated with shorter intervals of Plasmodium falciparum reinfections // Tissue antigens. - 2002. - Vol.59. - P.287-292.
62. Moraham G., Boutlis C., Huang D., Pain A., Saunders J., Hobbs M., Granger D., Weinberg J., Peshu N., Mwaikambo E., Marsh K., Roberts D., Anstey N. A promoter polymorphism in the gene encoding IL-12p40 (IL12B) is associated with mortality from cerebral malaria and with reduced nitric oxide production // Genes Immunol.- 2002.- Vol.3. - P.414-418.
63. Mosmann T., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more // Immunol. Today. - 1996. - Vol.17.- N 3. - P.138-146.
64. Muhl H., Pfeilschifter J. IL-18 bioactivity: a novel target for immunopharmacological anti-inflammatory intervention // Eur. J. Parmacol. - 2004. - Vol.500. – N 1-3. - P.63-71.
65. Nash P., Barrett J., Cao J.-X., Hota-Mitchell Sh., Labani A. Immunomodulation by viruses: the myxoma virus story // Immunol. Rev. - 1999. - Vol.168. - P.103-120.
66. Netea M., Sutmuller R., Hermann C., Van der Graaf C., Van der Meer J., van Krieken J., Hartung T., Adema G., Kullberg B. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells // J. Immunol. - 2004. - Vol.172. - N 6. - P.3712-3718.
67. Noone C., Lewis E., Frawely A., Newman R., Mahon B., Mills K., Johnson P. Novel mechanism of immunosuppression by influenza virus haemagglutinin: selective suppression of IL-12 p35 transcription in murine bone marrow-derived dendritic cells // J. Gen. Virol. - 2005. - Vol.86 (Pt 7). - P.1885-1890.
68. Novick D., Schwartsburd B., Pinkus R., Suissa D., Belzer I., Sthoeger Z., Keane W., Chvatchko Y., Kim S., Fantuzzi G., Dinarello C., Rubinstein M. A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18 // Cytokine. - 2001. - Vol.14. - N 6. - P.334-342.
69. Palosaari H., Parisien J., Rodriguez J., Ulane C., Horvath C. STAT protein interference and suppression of cytokine signal transduction by measles virus V protein // J. Virol. - 2003. - Vol.77. - N 13. - P.7635-7644.
70. Papiernik M. Natural CD4+CD25+ regulatory T cells. Their role in the control of superantigen responses // Immunol. Rev. - 2001. - Vol.182. - P.180-189.
71. Pasare Ch., Medzhitov R. Toll-dependent control mechanisms of CD4 T cell activation // Immunity. - 2004. - Vol.21. - N 5. - P.733-741.
72. Portnoy D. Manipulation of innate immunity by bacterial pathogens // Curr. Opin. Immunol. - 2005. - Vol.17. - N 1. - P.25-28.
73. Redmond W., Sherman L. Peripheral tolerance of CD8 T lymphocytes // Immunity. - 2005. - Vol.22. - P.275-284.
74. Roncarolo M., Bacchetta R., Bordignon C., Narula S., Levings M.K. Type 1 T regulatory cells // Immunol. Rev. - 2001. - Vol.182. - P.68-79.
75. Sasaki K., Tsutsumi A., Wakamiya N., Ohtani K., Suzuki Y., Watanabe Y., Nakayama N., Koike T. Mannose-binding lectin polymorphisms in patients with hepatitis C virus infection // Scand. J. Gastroenterol. - 2000. - Vol. 35. - N 9. - P.960-965.
76. Schaefer G., Venkatamaran C., Schindler U. Cutting edge: FISP (IL-4-induced secreted protein), a novel cytokine-like molecule secreted by Th2 cells // J. Immunol. - 2001. - Vol.166. - P.5859-5863.
77. Singh B., Reads S., Asseman C., Malmstrom V., Mottet C., Stephens L., Stepankova R., Tlaskalova H., Powrie F. Control of intenstinal inflammation by regulatory T cells // Immunol. Rev. - 2001. - Vol.182. - P.190-200.
78. Stauffer Y., Marguerat S., Meylan F., Ucla C., Sutkowski N., Huber B., Pelet T., Conrad B. Interferon-a-induced endogenous superantigen. A model linking environment and autoimmunity // Immunity. - 2001. - Vol.15. – P.591-602.
79. Sutkowski N., Conrad B., Thorley-Lawson D., Huber B. Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen // Immunity. - 2001. - Vol.15. - P.579-590.
80. Tanner J., Alfieri C. Epstein-Barr virus induces Fas(CD95) in T-cells and Fas ligand in B-cells leading to T-cell apoptosis // Blood. - 1999. - Vol.94. - N 10. - P.3439-3447.
81. Tateda K., Ishii Y., Yamaguchi K. Quorumsensing system of Pseudomonas aeruginosa - a novel target for antibacterial agents // Nippon Saikingaku Zasshi. - 2004. - Vol.59. - N 4. - P.543-549.
82. Tseng C., Klimpel G. Binding of the HVC envelope protein E2 to CD81 inhibits NK cell function // J. Exp. Med. - 2002. - Vol.195. - P.43-49.
83. Van de Vosse E., Lichtenauer-Kaligis E., van Dissel J., Ottenhoff T. Genetic variations in the IL-12/IL-23 receptor (beta1) chain, and implications for IL-12 and IL-23 receptor structure and function // Immunogenetics. - 2003. - Vol.54. - N12. - P.817-829.
84. Villarino A., Hibbert L., Lieberman L., Wilson E., Mak T., Yoshida H., Kastelein R., Saris C., Hunter C. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection // Immunity. - 2003. - Vol.19. - N5. - P.641-644.
85. Vink C., Smit M., Leurs R., Bruggeman C. The role of cytomegalovirus-encoded homologs of G proteincoupled receptors and chemokines in manipulation of and evasion from the immune system // J. Clin. Virol. - 2001. - Vol.23. - N 1-2. - P.43-55.
86. Weiner H. Induction and mechanism of action of TGF-b-secreting Th3 regulatory cells // Immunol. Rev. - 2001. - Vol.182. - P.207-214.
87. Wucherpfennig K. Structural basis of molecular mimicry // J. Autoimmunity. - 2001. - Vol.16. - P. 293-302.
88. Yamamoto A., Deschamps I., Garchon H., Roussely H., Moreau N., Beaurain G., Robert J.J., Bach J.F. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children // J. Autoimmunity. - 1998. - Vol.11. - N 6. - P.643-650.
Review
For citations:
Zheleznikova G.F. INFECTION AND IMMUNITY: STRATEGIES FROM BOTH SIDES. Medical Immunology (Russia). 2006;8(5-6):597-614. (In Russ.) https://doi.org/10.15789/1563-0625-2006-5-6-597-614
Views:
1355
Email this article 